Responses
Poster Presentations
Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
SAT0326 Effects of IL-1β (Canacinumab) and Betametazone on Glucose Metabolism and Pro-Inflammatory Cytokine Levels in Patients with Gout
Compose a Response to This Article
Other responses
No responses have been published for this article.